Discovery of NLGN4Y as A Potential Drug Target for Neurological Disorders

Target Name: NLGN4Y

NCBI ID: G22829

NLGN4Y

Discovery of NLGN4Y as A Potential Drug Target for Neurological Disorders

NLGN4Y, also known as neuroligin 4Y (NLGN4Y), is a protein that is expressed in the brain and is involved in the development and maintenance of neural circuits. It is a member of the neurotrophic factor family, which includes proteins that are involved in the support and maintenance of neural circuits.

The discovery and characterization of NLGN4Y was made by a team of researchers at the University of California, San Diego (UCSD). The researchers identified NLGN4Y as a potential drug target and used a variety of techniques to study its function in neural circuits.

One of the key findings of the study was that NLGN4Y was involved in the development of new neural connections, or synapses, in the brain. This is important because synapses are the structures that allow neurons to communicate with each other and are critical for the development and function of neural circuits. The researchers found that NLGN4Y was involved in the formation of new synapses, as well as the maintenance of existing ones.

Another important finding of the study was that NLGN4Y was involved in the regulation of neural circuit size and the maintenance of neural circuit stability. This is important because maintaining the size and stability of neural circuits is critical for the proper functioning of neural circuits and for the development and function of neural circuits. The researchers found that NLGN4Y was involved in the regulation of neural circuit size and stability, as well as the formation of new synapses.

In addition to its role in neural circuit development and maintenance, NLGN4Y was also found to be involved in the regulation of neural circuit function. The researchers found that NLGN4Y was involved in the regulation of neurotransmitter release, which is important for the proper functioning of neural circuits.

The potential drug targets for NLGN4Y are still being studied, but the research suggests that it may be a valuable tool for the development of new treatments for a variety of neurological and psychiatric disorders. The discovery and characterization of NLGN4Y as a potential drug target is a promising development in the field of neuroscience and may lead to new treatments for a variety of neurological and psychiatric disorders.

Protein Name: Neuroligin 4 Y-linked

Functions: Cell surface protein involved in cell-cell-interactions via its interactions with neurexin family members

The "NLGN4Y Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NLGN4Y comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets